VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

1,536 hedge funds and large institutions have $107B invested in Vertex Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 117 funds opening new positions, 606 increasing their positions, 605 reducing their positions, and 145 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1,536
Holders Change
-59
Holders Change %
-3.7%
% of All Funds
20.58%
Holding in Top 10
16
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-38.46%
% of All Funds
0.21%
New
117
Increased
606
Reduced
605
Closed
145
Calls
$930M
Puts
$554M
Net Calls
+$376M
Net Calls Change
+$202M

Top Buyers

1
Capital International Investors
Capital International Investors
California
+$884M
2
Victory Capital Management
Victory Capital Management
Texas
+$836M
3
Capital Research Global Investors
Capital Research Global Investors
California
+$700M
4
Jennison Associates
Jennison Associates
New York
+$485M
5
UBS AM
UBS AM
Illinois
+$226M

Top Sellers

1
Amundi
Amundi
France
-$898M
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$840M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$588M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$330M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$286M
Name Holding Trade Value Shares
Change 		Shares
Change %
Capital World Investors
1
Capital World Investors
California
$12.8B +$88.5M +198,835 +0.7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$10.7B +$215M +482,616 +2%
BlackRock
3
BlackRock
New York
$9.74B +$39.6M +89,012 +0.4%
Capital Research Global Investors
4
Capital Research Global Investors
California
$7.17B +$700M +1,571,947 +11%
State Street
5
State Street
Massachusetts
$5.24B -$5.98M -13,430 -0.1%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$2.85B -$588M -1,320,812 -17%
Jennison Associates
7
Jennison Associates
New York
$2.74B +$485M +1,089,063 +22%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$2.63B +$74M +166,987 +3%
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$2.61B -$840M -1,886,284 -24%
Wellington Management Group
10
Wellington Management Group
Massachusetts
$2.14B -$286M -641,362 -12%
AllianceBernstein
11
AllianceBernstein
Tennessee
$1.95B +$189M +424,808 +11%
Loomis, Sayles & Company
12
Loomis, Sayles & Company
Massachusetts
$1.7B +$29M +65,047 +2%
Norges Bank
13
Norges Bank
Norway
$1.59B +$1.59B +3,580,356 New
Morgan Stanley
14
Morgan Stanley
New York
$1.48B -$34.3M -77,081 -2%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$1.41B +$108M +242,643 +8%
UBS AM
16
UBS AM
Illinois
$1.37B +$226M +507,997 +20%
Bank of America
17
Bank of America
North Carolina
$1.25B -$25.5M -57,381 -2%
Northern Trust
18
Northern Trust
Illinois
$1.18B +$17.4M +39,189 +1%
Capital International Investors
19
Capital International Investors
California
$1.17B +$884M +1,986,004 +306%
Janus Henderson Group
20
Janus Henderson Group
United Kingdom
$1.17B -$57.2M -128,403 -5%
Edgewood Management
21
Edgewood Management
Connecticut
$1.09B -$84.2M -189,079 -7%
Ameriprise
22
Ameriprise
Minnesota
$971M -$24.1M -54,107 -2%
Victory Capital Management
23
Victory Capital Management
Texas
$968M +$836M +1,861,279 +633%
Invesco
24
Invesco
Georgia
$883M +$61.6M +138,406 +7%
Goldman Sachs
25
Goldman Sachs
New York
$860M +$87.8M +197,166 +11%
1
2 3 4 5